Gum disease gel: could spermidine make deep cleaning more effective?
NCT ID NCT06792916
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study tests whether adding a spermidine-based gel to standard deep-cleaning (MINST) improves gum pocket reduction in adults with periodontitis. Participants receive either the gel plus cleaning or cleaning alone, and gum health is tracked for 12 months. The goal is to see if the gel helps gums heal better and reduces bleeding.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a spermidine-based gel applied locally to the gums
- What this could lead to
- If it works, this could offer a simple, non-surgical way to improve gum healing and reduce pocket depth in people with periodontitis.
- What could go wrong
- This is a very small early-phase trial with only 13 participants, so results may not apply widely. The gel may not provide additional benefit over standard care alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
13 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Age 18 years or older. Presence of untreated periodontitis with at least 2 sites showing clinical attachment loss (CAL) \> 2 mm and probing depth (PD) \> 4 mm. Voluntary signing of informed consent. Exclusion Criteria: Presence of systemic diseases (e.g., diabetes mellitus, cardiovascular, renal, hepatic, or pulmonary conditions). Smokers (≥10 cigarettes per day). Pregnancy or breastfeeding. Allergy to any ingredients in the products used in the study. Diseases affecting bone and/or connective tissue metabolism.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Peridontitis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOU Federico II
Naples, Italy, 80013, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.